Nalaganje...
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
INTRODUCTION: Dupilumab significantly improves signs and symptoms of atopic dermatitis (AD), including pruritus, symptoms of anxiety and depression, and health-related quality of life versus placebo in adults with moderate-to-severe AD. Since the cost-effectiveness of dupilumab has not been evaluate...
Shranjeno v:
| izdano v: | Dermatol Ther (Heidelb) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Healthcare
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698200/ https://ncbi.nlm.nih.gov/pubmed/28933010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-017-0201-6 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|